A retrospective study looked at older adults with pulmonary infections treated at a hospital in China. The team compared those who received Chinese herbal medicine alongside conventional treatment to those who received conventional treatment alone. The group taking the herbal medicine had shorter hospital stays and shorter periods of fever. They also showed faster recovery in symptoms and oxygen levels, plus better results on inflammatory markers and reductions in drug-resistant bacteria counts.
The study found no significant difference in overall mortality or in reversing drug-resistant bacteria between the two groups. Safety data were not reported in detail, but no adverse events or discontinuations were noted in the available records. Researchers used statistical methods to adjust for differences between groups and confirmed their findings remained consistent.
Because this was a retrospective study, the results show an association rather than proof of cause. Further research is required to confirm these benefits and to optimize treatment protocols before this approach becomes standard practice.
